To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Study of Tamoxifen and RaloxifeneThe Study of Tamoxifen and Raloxifene or STAR is a clinical trial designed determine how the drug raloxifene compares with the drug tamoxifen in reducing the incidence of breast cancer in postmenopausal women who are at increased risk of the disease. One of the largest breast cancer prevention studies ever, STAR took place at more than 500 centers across the United States, Canada, and Puerto Rico. |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Study_of_Tamoxifen_and_Raloxifene". A list of authors is available in Wikipedia. |
Last viewed
